<DOC>
	<DOCNO>NCT02789982</DOCNO>
	<brief_summary>The purpose study : ( 1 ) examine effectiveness reconsolidation blockade treatment trauma-related disorder , ( 2 ) evaluate feasibility implement new treatment large scale short delay . This clinical trial set response Paris attack increase treatment capacity AP-HP ( Assistance Publique de Hopitaux de Paris ) hospital network.. Reconsolidation blockade compare treatment usual ( TAU ) , symptom reduction 6 week treatment . In order measure effectiveness cost-effectiveness , socioeconomic measure , quality life social functioning outcome measure pre- post-treatment well 3 12 month study enrollment .</brief_summary>
	<brief_title>Using Reconsolidation Blockade Treat Trauma Related Disorders After Paris Attacks : Effectiveness Study</brief_title>
	<detailed_description>The November 13th Paris attack violent devastate event occur France since World War II . A large number person likely develop PTSD trauma-related disorder , especially victim directly involve , family , well first responder . In context , urgent need enhance treatment resource . Psychotherapy known effective costly , require qualified professional . Pharmacotherapy ( e.g. , selective serotonin reuptake inhibitor , SSRIs ) also consider effective . However , side effect often lead patient abandon treatment . An alternative evidence-based intervention use β-adrenergic blocker propranolol use interfere reconsolidation recall traumatic memory , reduce strength time . This clinical trial evaluate effectiveness cost-effectiveness reconsolidation blockade compare treatment usual . The study involve four assessment : pre- post-treatment 13 week 1 year follow . The outcome measure include : PTSD symptom , socioeconomic variable , quality life social functioning measure . The investigator hypothesize patient improve . However , patient receive reconsolidation blockade recover faster treatment usual . Finally , investigator hypothesize reconsolidation blockade well accepted professional patient .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Adrenergic Antagonists</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<mesh_term>Adrenergic Agents</mesh_term>
	<criteria>Age 18 year old Fluency French Suffer PTSD , adjustment disorder specify trauma stressorrelated disorder PTSD Checklist Specific ( PCLS ) &gt; 44 Clinical Global Impression ( CGI ) &gt; 3 Reconsolidation blockade group : Resting heart rate &lt; 55 beat per minute Resting systolic blood pressure &lt; 100 mm Hg A history congestive heart failure , hypoglycemic medicationrequiring diabetes , chronic bronchitis asthma . Brain injury Previous adverse reaction βadrenergic blocker Current use βadrenergic blocker Current use medication involve potentially dangerous interaction propranolol Both group : Current pregnancy ( Positive pregnancy test ) breastfeed Currently suicidal homicidal Contraindicating neuropsychiatric condition , e.g. , current psychotic , bipolar , substance dependence abuse disorder Patients use SSRI le 2 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>PTSD</keyword>
	<keyword>Trauma relate disorder</keyword>
	<keyword>Reconsolidation blockade</keyword>
	<keyword>Paris attack</keyword>
</DOC>